Wipro Consumer Care buys 60% of Dermatouch at ₹387.5 crore valuation

Wipro Consumer Care & Lighting has acquired a 60% stake in digital-first skincare brand Dermatouch, with an agreement to buy the remaining 40% over three years. The deal gives Wipro its first digital-brand acquisition and adds a fast-growing skincare platform to its beauty portfolio.

— Source published Tue, 18 Aug, 2026, 18:37 IST · First seen Tue, 18 Aug, 2026, 18:59 IST · Source Financial Express · BrandWagon

What happened

Wipro Consumer Care & Lighting acquired a 60% stake in digital-first skincare brand Dermatouch at a Rs 387.5 crore enterprise value, marking its first

Key facts

  • 60% stake in Dermatouch acquired
  • Dermatouch enterprise value: Rs 387.5 crore
  • Remaining 40% stake to be acquired
  • TTK Healthcare's Good Home and Eva acquired for Rs 256 crore
  • Dermatouch FY26 revenue: Rs 131 crore, up 114% year-on-year
  • Dermatouch sales volume: over 60,000 products per day
  • Wipro Consumer Care & Lighting FY26 revenue: Rs 10,800 crore, up 9.3%
  • Wipro Consumer Care's 18th global acquisition

Why this matters

Buying 60% of Dermatouch with a staged path to full ownership provides Wipro a lower-risk entry into digital-first beauty while securing a scalable skincare platform for its portfolio.

What to watch

  • Dermatouch revenue growth and whether it sustains above-category expansion after the acquisition.
  • Gross margin, EBITDA trajectory and customer-acquisition-cost versus repeat-purchase trends.
  • Offline distribution rollout, especially pharmacy and modern-trade door count.
  • New product-launch cadence and evidence-backed claims that differentiate the brand from crowded D2C skincare peers.
  • Changes in founder/management retention and the terms or timing of Wipro's purchase of the remaining 40%.
  • Competitive response from large FMCG beauty players, dermatology brands and ecommerce-native skincare entrants.
  • Accelerate Dermatouch distribution into pharmacies, modern trade, beauty stores and Wipro's existing retail channels.
  • Expand clinically positioned skincare lines in acne, pigmentation, sunscreen, hair/scalp and dermocosmetic adjacencies.
  • Increase spending on creator marketing, marketplace visibility, subscriptions and CRM to protect digital growth.
  • Build a clearer dermatology and claims-validation pipeline using Wipro R&D and external clinical partners.
  • Prepare the staged acquisition of the remaining 40% through performance-linked governance, reporting and retention arrangements.